A single subcutaneous dose led to a 4-point or greater itch reduction in 82% of patients with chronic pruritus at week 12 vs ...

Jessica Scales, PhD, of the Melanoma Research Alliance, reviewed clinical trial access and clinician involvement in the RARE ...

Eingun James Song, MD, explains bone alkaline phosphatase trends and growth considerations in pediatric atopic dermatitis.

Jessica Scales, PhD, of the Melanoma Research Alliance, discussed the new RARE Registry data report and dermatologists’ role ...

The AADA warns that dermatologists could face a 6% Medicare payment reduction in 2027 despite CMS revisions to modifier 25 policies.

One clinical trial widened a patient's time in the sun, yet fear of hidden light sources remained. The conversation also ...

Mark Lebwohl, MD, describes his approach on when to start systemic therapy, access considerations, and dupilumab safety and ...

Two oral trial drugs changed one patient's daily life, culminating in his first beach visit without protective gear. He and ...

Patients on Medicare often do everything insurers ask, including trying and failing the standard topicals, and still can’t ...

A melanoma expert discusses gaps in dermoscopy education, cognitive bias during skin examinations, and strategies to improve ...

Trickett and Neita compare adalimumab, secukinumab, and bimekizumab trial data and explain how comorbidities guide biologic ...

An 83-year-old patient's three-decade psoriasis journey, shaped by a comorbid MGUS diagnosis and a hospitalization that ...